Schizophrenia Archives - Page 18 of 25

Recovery In Schizophrenia: What Consumers Know & Do Not Know

Article August 1, 2017

Key Messages Traditional medical model interventions for schizophrenia have a focus on decreasing symptoms and disability In contrast, recovery-oriented interventions include the treatment targets of hope, empowerment, meaning, identity, and… Read More

No Supportive Evidence For The Use Of Multiple Long-Acting Antipsychotic Therapies In Patients With Schizophrenia

Article July 27, 2017

Does anyone use multiple LAI medications on one patient? Although over a third of patients with schizophrenia in the United States receive 2 or more antipsychotic medications, no combination of… Read More

A Tool To Predict Risk Of Violence In Individuals With Schizophrenia Spectrum Or Bipolar Disorder

Article July 26, 2017

A group of researchers from the United Kingdom and Sweden developed a tool to predict the risk of violence in people with schizophrenia spectrum or bipolar disorder. A report “Identification… Read More

Cerebral White Matter Structure Is Associated With DSM-5 Schizophrenia Symptom Dimensions

Article July 11, 2017

Key Messages This diffusion tensor imaging (DTI) study examined associations between white matter (WM) microstructure and the severity of the 5 main Diagnostic and Statistical Manual of Mental Disorders, Fifth… Read More

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

Article July 11, 2017

Key Messages White matter (WM) pathology and neuroinflammation have each been associated with schizophrenia in separate lines of research. This systematic literature review examined whether a relationship exists between WM… Read More

Neuroinflammation & Psychiatric Illness

Article June 26, 2017

Key Messages Multiple lines of evidence support the role of neuroinflammatory processes in the pathogenesis of psychiatric illnesses. Neuropsychiatric disorders are frequently found among patients with autoimmune conditions; in addition,… Read More

Genetics Of Schizophrenia & Smoking: An Approach To Studying Their Comorbidity Based On Epidemiological Findings

Article June 26, 2017

Key Messages An association between tobacco smoking and schizophrenia has been consistently described in the literature. This meta-analysis showed a 5-fold increased rate of current smoking in patients with schizophrenia… Read More

Genetic Correlates Of Medical Comorbidity Associated With Schizophrenia & Treatment With Antipsychotics

Article June 26, 2017

Key Messages Genetic factors are suspected to contribute to the high comorbidity rate for medical conditions in patients with schizophrenia. Key findings from genetic studies include: Comorbid impaired glucose tolerance/type… Read More

Stigma & Discrimination Experienced By People Living With Severe & Persistent Mental Illness In Assertive Community Treatment Settings

Article June 26, 2017

Key Messages This study, which examined experiences of discrimination from the patient’s perspective among 50 people living with severe and persistent mental illness, found that discrimination is encountered in many everyday… Read More

Dopamine Theory & Treatment Considerations In Schizophrenia

Video June 8, 2017

This video is part 1 in a series focusing on the psychopharmacology of schizophrenia. This video provides an overview of the hypothesis that altered dopamine levels underlie schizophrenia symptomatology and… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: